BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  C2C Services & Suppliers™
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile

 

Navidea Biopharmaceuticals 

425 Metro Place Northurt
Suite 400
Dublin  Ohio  43017  U.S.A.
Phone: 614-793-7500 Fax: 614 793 7520


SEARCH JOBS




Industry
Medical Device






 Company News
Navidea Biopharmaceuticals (NAVB) Announces Presentation Of Lymphoseek Data At Society Of Surgical Oncology Meeting 3/25/2015 10:32:44 AM
Macrophage Therapeutics, A Subsidiary Of Navidea Biopharmaceuticals (NAVB), Executes Securities Purchase Agreement For $2.5 Million Financing And Receives Initial Funding 3/16/2015 10:59:31 AM
CLARIFICATION Of Navidea Biopharmaceuticals (NAVB) Announces Fourth Quarter And Full Year 2014 Results 3/5/2015 11:18:39 AM
Navidea Biopharmaceuticals (NAVB) And Norgine Enter European Commercial Partnership For Lymphoseek; Navidea To Receive $2 Million Upfront Payment 3/5/2015 11:01:23 AM
Macrophage Therapeutics, A Subsidiary Of Navidea Biopharmaceuticals (NAVB), Appoints Leading Experts To Therapeutics-Focused Scientific Advisory Board 2/27/2015 11:47:17 AM
Navidea Biopharmaceuticals (NAVB) To Announce Fourth Quarter And Year-End 2014 Financial Results On March 5, 2015 2/26/2015 11:47:23 AM
Navidea Biopharmaceuticals (NAVB) Release: Lymphoseek Data Presented In European Medical Conference Reinforces Clinical Value In Head & Neck Cancer Of The Oral Cavity 2/18/2015 10:44:54 AM
Navidea Biopharmaceuticals (NAVB) Release: Lymphoseek Results From Phase 3 Clinical Trial In Oral Cavity Cancer Of The Head And Neck Published In Annals Of Surgical Oncology 2/17/2015 10:59:42 AM
Navidea Biopharmaceuticals (NAVB) Reports Preliminary 2014 Revenue; Provides Update On New Commercial Strategy 2/9/2015 9:50:01 AM
Navidea Biopharmaceuticals (NAVB) To Report Preliminary 2014 Revenue And Present At Biotechnology Industry Organization (BIO) CEO & Investor Conference February 9 2/3/2015 12:02:21 PM
12345678910...